128 studies found for:    caregivers and alzheimer's | United States, Florida
Show Display Options
Rank Status Study
1 Completed Observational Study on Costs and Caregiver Burden in Alzheimer's Disease
Condition: Alzheimer's Disease
2 Completed
Has Results
A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease
Condition: Dementia of the Alzheimer's Type
Interventions: Drug: memantine ER;   Drug: Placebo
3 Completed
Has Results
A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: dl-alpha-tocopherol;   Drug: Memantine;   Drug: Placebo
4 Terminated
Has Results
A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: Dimebon 20 mg po TID;   Drug: Placebo po TID
5 Completed Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Rosiglitazone Extended Release 2mg;   Drug: Rosiglitazone Extended Release 8mg;   Other: Placebo;   Other: Donepezil;   Other: Galantamine;   Other: Rivastigmine
6 Completed Coordinating Center for Caregiver Intervention Trial
Conditions: Dementia;   Alzheimer Disease
Intervention: Procedure: multicomponent psychosocial intervention
7 Completed Coordinating Center for Enhancing ADRD Caregiving
Conditions: Dementia;   Alzheimer Disease
Interventions: Procedure: Skill Training Condition – problem solving training;   Procedure: REACH for TLC (Telephone Linked Computer) system
8 Completed Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
Conditions: Agitation;   Alzheimer's Disease
Interventions: Drug: AVP-923 (dextromethorphan/quinidine);   Drug: Placebo
9 Enrolling by invitation Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025
Conditions: Alzheimer's Disease;   Dementia
Intervention: Drug: EVP-6124
10 Completed Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Rosiglitazone
11 Completed Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil
Condition: Alzheimer's Disease
Interventions: Drug: Dimebon;   Drug: Placebo comparator
12 Completed ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301)
Condition: Alzheimer's Disease
Intervention: Drug: VP4896
13 Completed Effect of Different Doses of SAR110894D on Cognition in Patients With Mild to Moderate Alzheimer's Disease on Donepezil
Condition: Dementia Alzheimer's Type
Interventions: Drug: SAR110894D;   Drug: placebo
14 Completed Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)
Condition: Alzheimer's Disease
Interventions: Drug: Donepezil;   Drug: AZD3480
15 Completed Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia
Intervention: Drug: Donepezil hydrochloride
16 Completed The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
Condition: Mild to Severe Alzheimer's Disease
Intervention: Drug: Donepezil HCl
17 Terminated Phase 3 IGIV, 10% in Alzheimer´s Disease
Condition: Alzheimer´s Disease
Interventions: Biological: Immune Globulin Intravenous (Human), 10% Solution;   Biological: Human albumin 0.25%
18 Unknown  Trial of Novel Oral Zinc Cysteine Preparation in Alzheimer's Disease
Conditions: Alzheimer's Disease;   Mild Cognitive Impairment
Interventions: Other: Gastro-retentive zinc cysteine tablet;   Other: Tablet identical physically to active comparator containing some lactose
19 Completed CATIE-Alzheimer's Disease Trial
Condition: Alzheimer's Disease
Interventions: Drug: Olanzapine;   Drug: Quetiapine;   Drug: Risperidone;   Drug: Citalopram
20 Recruiting Improving Dementia Caregiver Sleep & the Effect on Heart Disease Biomarkers
Condition: Caregivers of Persons With Dementia
Interventions: Behavioral: Sleep Behavioral Therapy A and NHMS;   Behavioral: Sleep Behavioral Therapy B and NHMS

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years